Literature DB >> 20728984

Metastases to Meckel's cave: report of two cases and comparative analysis of malignant tumors with meningioma and schwannoma of Meckel's cave.

Chetan R Soni1, Gyanendra Kumar, Pradeep Sahota, Douglas C Miller, Norman S Litofsky.   

Abstract

OBJECTIVE: To investigate clinical characteristics of patients with malignant tumors of Meckel's cave with two illustrative cases. A comparative analysis of clinical features of malignant tumors of Meckel's cave with meningioma and schwannoma of Meckel's cave is discussed.
METHODS: We report two cases of malignant tumors involving Meckel's cave. We identified 19 additional cases of malignant tumors of Meckel's cave in the literature. We analyzed the symptoms, results of neurological and radiographic examination, pre-operative diagnosis and final diagnosis of these tumors. Our findings were then compared with well described case series of meningioma and schwannoma involving Meckel's cave.
RESULTS: Of the 21 patients with malignant tumor involving Meckel's cave, 76% (16/21) had pain, 67% (14/21) had paraesthesia, 89% (17/21) had objective evidence of trigeminal sensory involvement and 42% (8/21) had objective evidence of trigeminal motor involvement. In contrast, of patients with trigeminal schwannomas [1], only 23% presented with pain, 36% with paraesthesia, 74% with objective evidence of trigeminal involvement and 42% with trigeminal motor involvement. Pain and paraesthesia were seen more often in malignant tumors. In Delfini et al.'s [2] series of meningiomas involving Meckel's cave, 81% of patients presented with pain, 25% with paraesthesia, 63% with trigeminal sensory deficits and only 13% with trigeminal motor involvement. Patients with malignant tumors were more likely to be older, and have paraesthesia in comparison with patients with meningioma.
CONCLUSION: Subtle clinical clues may help differentiate malignant from benign involvement of Meckel's cave. We emphasize the need to thoroughly investigate patients early for a possible primary as well as metastases, in those found to have a lesion in the Meckel's cave.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728984     DOI: 10.1016/j.clineuro.2010.07.019

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

1.  Concurrent metastases of papillary thyroid carcinoma to the scalp and Meckel's cave.

Authors:  Patrick S Phelan; Jamie L Mull; Mohamed Z Rajput; Amy C Musiek
Journal:  BMJ Case Rep       Date:  2018-06-17

2.  Unraveling a cephalalgic quagmire from a cavern to a cave.

Authors:  S Thenmozhi; S Girija; K N Viswanathan; K V Karthikeyan
Journal:  J Postgrad Med       Date:  2021 Apr-Jun       Impact factor: 1.476

3.  Symptomatic Meckel's Cave Metastasis from Castration-resistant Prostate Cancer Treated with Gamma Knife Radiosurgery.

Authors:  Leonid Reshko; Martin K Richardson; Kelly Spencer; William H McAllister Iv; Charles R Kersh
Journal:  Cureus       Date:  2018-06-19

Review 4.  Neuroimaging of Meckel's cave in normal and disease conditions.

Authors:  Ajay Malhotra; Long Tu; Vivek B Kalra; Xiao Wu; Ali Mian; Rajiv Mangla; Elias Michaelides; Pina Sanelli; Dheeraj Gandhi
Journal:  Insights Imaging       Date:  2018-04-18

5.  Diffuse large B cell lymphoma involving Meckel's cave masquerading as biopsy-negative giant cell arteritis: a case report.

Authors:  Matthew J Samec; Andres G Madrigal; Charlotte H Rydberg; Matthew J Koster
Journal:  J Med Case Rep       Date:  2020-05-10

6.  Glioblastoma, IDH-wildtype with leptomeningeal metastasis to Meckel's cave: A case report.

Authors:  Toshiki Murata; Masazumi Matsuda; Tetsugaku Shinozaki; Koichi Ishiyama
Journal:  Acta Radiol Open       Date:  2022-10-07

7.  Metastatic epithelial ovarian cancer to Meckel's cave with leptomeningeal spread at time of diagnosis.

Authors:  Ryan Matthew Kahn; Shreena Kamlesh Gandhi; Mwamba Rebecca Mvula; Xuan Li; Melissa K Frey
Journal:  Gynecol Oncol Rep       Date:  2020-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.